Physician
Hematology
Dr. Leonardo N. Faoro, MD
|
|
Give Review
Leonardo Faoro practices Hematology. Leonardo Faoro is a published doctor and has 20 publications published. The lastest was: 'The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.'
Publications
- The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
- Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade ...
- Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
- Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non-Small-Cell Lung Cancer, A Phase II Trial.
- Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
- Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial.
- Generation of comprehensive thoracic oncology database--tool for translational research.
- BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untre...
- EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
- MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer.
- MET receptor tyrosine kinase.
- The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
- PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
- Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma.
- Protein kinase C beta in malignant pleural mesothelioma.
- Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and ...
- C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes.
- Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
- Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
University of Chicago -
Mayo School of Graduate Medical Education -
Federal University of Parana Faculty of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Adam M. Petrich, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Asha R. Dhanarajan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seshan Subramanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin P. Kline, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa L. Larson, MD |
|
|
Dr. Leonard A. Kosova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shweta Gupta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard G. Ghalie, MD |